Publications by authors named "Sohel Talib"

Claim this Profile
S
Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease.
Mary Eapen, Ruta Brazauskas, David A Williams, Mark C Walters, Andrew St Martin, Sohel Talib

J Clin Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enabling allogeneic therapies: CIRM-funded strategies for immune tolerance and immune evasion.
Lisa C Kadyk, Ross M Okamura, Sohel Talib

Stem Cells Transl Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unleashing the cure: Overcoming persistent obstacles in the translation and expanded use of hematopoietic stem cell-based therapies.
Sohel Talib, Kelly A Shepard

Stem Cells Transl Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings: human leukocyte antigen haplo-homozygous induced pluripotent stem cell haplobank modeled after the california population: evaluating matching in a multiethnic and admixed population.
Derek James Pappas, Pierre-Antoine Gourraud, Caroline Le Gall, Julie Laurent, Alan Trounson, Sohel Talib

Stem Cells Transl Med· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings: Immune Tolerance and Stem Cell Transplantation: A CIRM Mini-Symposium and Workshop Report.
Sohel Talib, Maria T Millan, Rebecca L Jorgenson, Kelly A Shepard

Stem Cells Transl Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bottlenecks in deriving definitive hematopoietic stem cells from human pluripotent stem cells: a CIRM mini-symposium and workshop report.
Kelly A Shepard, Sohel Talib

Stem Cells Transl Med· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies.
Zachary S Scheiner, Sohel Talib, Ellen G Feigal

J Biol Chem· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation.
John D Roback, Mohammad S Hossain, Levan Lezhava, John W Gorechlad, Sabina A Alexander, Sohel Talib

J Immunol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photochemical treatment of donor lymphocytes inhibited their ability to facilitate donor engraftment or increase donor chimerism after nonmyeloablative conditioning or establishment of mixed chimerism.
Bryon D Johnson, Patricia A Taylor, Marja C Stankowski, Sohel Talib, John E Hearst

Biol Blood Marrow Transplant· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multilineage engraftment with minimal graft-versus-host disease following in utero transplantation of S-59 psoralen/ultraviolet a light-treated, sensitized T cells and adult T cell-depleted bone marrow in fetal mice.
Swati Bhattacharyya, Anjulika Chawla, Kristofer Smith, Yungui Zhou, Sohel Talib

J Immunol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis